Detalhe da pesquisa
1.
SARS-CoV-2 Prevalence in Malawi Based on Data from Survey of Communities and Health Workers in 5 High-Burden Districts, October 2020.
Emerg Infect Dis
; 28(13): S76-S84, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36502413
2.
Enhancing SARS-CoV-2 surveillance in Malawi using telephone syndromic surveillance from July 2020 to April 2022.
BMJ Glob Health
; 9(5)2024 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38754899
3.
Coronavirus Disease 2019 (COVID-19) Reinfection Rates in Malawi: A Possible Tool to Guide Vaccine Prioritisation and Immunisation Policies.
Vaccines (Basel)
; 11(7)2023 Jun 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37515002
4.
Safety of Janssen Ad26.COV.S and Astra Zeneca AZD1222 COVID-19 Vaccines among Mobile Phone Users in Malawi: Findings from a National Mobile-Based Syndromic Surveillance Survey, July 2021 to December 2021.
Int J Environ Res Public Health
; 20(23)2023 Nov 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38063553
5.
Draft genomes of Aeromonas caviae from patients with cholera-like illness during the 2022-2023 cholera outbreak in Malawi.
Microbiol Resour Announc
; 12(10): e0058023, 2023 Oct 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-37768056
6.
Omicron B.1.1.529 variant infections associated with severe disease are uncommon in a COVID-19 under-vaccinated, high SARS-CoV-2 seroprevalence population in Malawi.
EClinicalMedicine
; 56: 101800, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36600885